Pages that link to "Q34161201"

The following pages link to Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles (Q34161201):

Displaying 20 items.

• The Use of Synthetic Carriers in Malaria Vaccine Design (Q26777053) (← links)
• Engineered nanomaterial uptake and tissue distribution: from cell to organism (Q26861914) (← links)
• Uptake and metabolism of iron oxide nanoparticles in brain cells. (Q30838637) (← links)
• Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles (Q34017288) (← links)
• Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling (Q34571360) (← links)
• Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation (Q35037265) (← links)
• Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles (Q35343983) (← links)
• Manipulation of magnetic nanoparticle retention and hemodynamic consequences in microcirculation: assessment by laser speckle imaging (Q36058854) (← links)
• In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts. (Q36163322) (← links)
• Serum protein adsorption and excretion pathways of metal nanoparticles (Q36468223) (← links)
• Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. (Q37037910) (← links)
• Handling of iron oxide and silver nanoparticles by astrocytes (Q38066031) (← links)
• Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences (Q38494930) (← links)
• Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona (Q38865701) (← links)
• Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains. (Q41674454) (← links)
• The fate of a designed protein corona on nanoparticles in vitro and in vivo (Q41949987) (← links)
• Biohybrid nanostructured iron oxide nanoparticles and Satureja hortensis to prevent fungal biofilm development. (Q42663914) (← links)
• Plasma protein adsorption and biological identity of systemically administered nanoparticles (Q47570893) (← links)
• Technical tip: high-resolution isolation of nanoparticle-protein corona complexes from physiological fluids (Q48664150) (← links)
• The Role of the Protein Corona in Fiber Structure-Activity Relationships (Q58493134) (← links)